Marinus Pharmaceuticals
MRNS
#10575
Rank
NZ$55.16 M
Marketcap
NZ$1.00
Share price
0.00%
Change (1 day)
-61.28%
Change (1 year)

EPS for Marinus Pharmaceuticals (MRNS)

EPS in 2024 (TTM): NZ-$3.85

According to Marinus Pharmaceuticals's latest financial reports the company's current EPS (TTM) is NZ-$4.25. In 2022 the company made an earnings per share (EPS) of NZ-$0.74 an increase over its 2021 EPS that were of NZ-$4.89.

EPS history for Marinus Pharmaceuticals from 2020 to 2024

Annual EPS

Year EPS Change
2024 (TTM)NZ-$3.85
2022NZ-$0.74-84.76%
2021NZ-$4.89-9.12%
2020NZ-$5.38

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Supernus Pharmaceuticals
SUPN
NZ-$1.38-67.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Endo International
ENDPQ
NZ-$1.94-54.27%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
AcelRx Pharmaceuticals
ACRX
NZ-$4.05-4.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Eagle Pharmaceuticals
EGRX
NZ$2.16-150.85%๐Ÿ‡บ๐Ÿ‡ธ USA